Skip to main content
Top

Clinical & Experimental Metastasis

Issue 2/2005

Content (10 Articles)

Role of the β1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells

Christoph Heyder, Eva Gloria-Maercker, Wolfgang Hatzmann, Bernd Niggemann, Kurt S. Zänker, Thomas Dittmar

Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder

Christine L. Chaffer, Bonnie Dopheide, Daniel R. McCulloch, Allan B. Lee, Jane M. Moseley, Erik W. Thompson, Elizabeth D. Williams

The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion

María José Rico, Pablo Matar, Silvia I. Gervasoni, R. Daniel Bonfil, Nora Calcaterra, O. Graciela Scharovsky

Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis

Hayao Nakanishi, Kenzo Yasui, Yuzuru Ikehara, Hiroyuki Yokoyama, Seiichi Munesue, Yasuhiro Kodera, Masae Tatematsu

Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells

Xianyang Yio, Jie-yu Zhang, Mark Babyatsky, Anli Chen, Jing Lin, Qui-Xiang Fan, J. Lawrence Werther, Steven Itzkowitz

An Orthotopic Model of Lung Cancer to Analyze Primary and Metastatic NSCLC Growth in Integrin α1-Null Mice

Xiwu Chen, Yan Su, Barbara Fingleton, Heath Acuff, Lynn M. Matrisian, Roy Zent, Ambra Pozzi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine